#personalisedtherapies
LightNews LightNews
4040rec.bsky.social
#medicines #innovativetherapies #regulatorydataprotection #RDP #newmedicines #EFPIA #EU #EMA #IPprotections #RandDspending #Bolarclause #genericmedicines #IPenforcement #Europeanmedicinesregulation #personalisedtherapies #TEV #antibiotics #antimicrobials #EUpharmaceuticalreform
zurl.co/0ePeI
Agreement reached on EU's new pharma legislation
Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.
pharmaphorum.com
January 19, 2026 at 9:25 AM
pharmaphorum.bsky.social
FDA reveals a #regulatorypathway for #personalisedtherapies based on 'plausible mechanism', drawing on the bespoke gene-editing treatment of Baby KJ.
#FDA #PrecisionMedicine #RareDiseaseCommunity #RegulatoryInnovation #ClinicalInnovation #PharmaNews
pharmaphorum.com/news/fda-unv...
FDA unveils swift route to market for personalised drugs
FDA reveals a regulatory pathway for personalised therapies based on 'plausible mechanism', drawing on the bespoke gene-editing treatment of Baby KJ
pharmaphorum.com
November 13, 2025 at 12:31 PM
4040rec.bsky.social
#osteoarthritis #personalisedtherapies #genomewideassociationstudy #geneticdata #geneticvariations #osteoarthritisprevalence #biomedicaldatasets #geneticdiseaseassociatedvariants #osteoarthritisdevelopment #circadianclock #signallingpathways #diseasemechanisms
pharmatimes.com/news/hundred...
Hundreds of genetic links to osteoarthritis unlocked - PharmaTimes
Study paves the way for personalised therapies for osteoarthritis sufferer
pharmatimes.com
May 2, 2025 at 11:16 AM
healthcaretoday.bsky.social
Justin Stebbing, professor of Biomedical Sciences at Anglia Ruskin University and editor-in-chief of Oncogene, explains why mRNA cancer vaccines could become a new therapeutic modality.

healthcaretoday.com/article/mrna...

#vaccines #hpv #cancer #personalisedtherapies #healthcare #therapy #mrna
mRNA cancer vaccines: a new personalised therapy ready for real-time?
Justin Stebbing, professor of Biomedical Sciences at Anglia Ruskin University and editor-in-chief of Oncogene, explains why the vaccines could become a new therapeutic modality.
healthcaretoday.com
January 16, 2025 at 1:52 PM